Procedure Deep-Dive · November 15, 2026

Polycythemia Vera and Essential Thrombocythemia Before Cosmetic Surgery: Blood Clots, Bleeding, JAK2, Phlebotomy, Hydroxyurea, Aspirin, and Liposuction

Polycythemia vera and essential thrombocythemia are slow-growing blood cancers that make the marrow overproduce red cells or platelets, and they carry a paradox that matters in the operating room: a higher risk of blood clots and, in some patients, a higher risk of bleeding at the same time. Here is what these myeloproliferative neoplasms mean for liposuction, tummy tucks, breast surgery, and facelifts, why the hematocrit number on your last blood test matters more than almost anything else, and why the usual advice to stop aspirin and take iron before surgery can be exactly wrong.

By The Editorial Desk

21 min read

A man in his early fifties with short salt-and-pepper hair and a gray beard, wearing a dark green knit crew-neck sweater, seated in a taupe upholstered armchair beside a tall window with autumn trees outside, his hands resting near his knees as he looks out the window

He is 53, a high school principal, and for years he assumed his permanently flushed face was a drinker's complexion he had somehow earned without drinking. The itching came next: a fierce, prickling itch over his back and arms every time he stepped out of a warm shower. Then a routine physical turned up a hematocrit of 56 percent, a JAK2 gene test came back positive, and he was told he had polycythemia vera. Two years later his blood counts are controlled with regular blood draws, a daily baby aspirin, and a capsule of hydroxyurea. He has lost 40 pounds, and what bothers him now is the loose skin and stubborn fat around his middle. He has a consultation booked for liposuction and a tummy tuck. The intake form asks whether he has a "bleeding or clotting disorder," and he is not sure which box to tick, because the honest answer is both.

That uncertainty is the heart of this piece. Polycythemia vera and its close relative, essential thrombocythemia, belong to a family of conditions called myeloproliferative neoplasms, or MPNs. They are uncommon, chronic, and for most people compatible with a long life. But they change the arithmetic of elective surgery more than most conditions on a cosmetic intake form, because they push the blood toward clotting and, in certain circumstances, toward bleeding. This piece covers what PV and ET are, what needs to be controlled before surgery, which medications matter, how each procedure changes, and what the weeks after surgery should look like.

Polycythemia vera and cosmetic surgery: what PV and ET are, and why they matter in the operating room

The short answer: polycythemia vera and essential thrombocythemia are chronic blood cancers in which the bone marrow overproduces red blood cells, platelets, or both, and they matter for cosmetic surgery because they sharply raise the risk of blood clots after an operation and, in some patients, the risk of bleeding as well.

The word "cancer" alarms people, and it should be put in context. MPNs are classified as blood cancers because they arise from an acquired genetic change in a single marrow stem cell that then multiplies without the usual controls. But most people with PV or ET live for decades after diagnosis, many with a life expectancy close to that of their peers, and the main threats to their health are not the marrow itself but its consequences: clots, and less often bleeding. A small proportion progress over many years to scarring of the marrow (myelofibrosis) or, rarely, to acute leukemia.

Polycythemia vera is defined by too many red blood cells. The blood becomes thicker, flows more sluggishly, and clots more readily. More than 95 percent of people with PV carry an acquired mutation called JAK2 V617F, which switches on the growth signaling in marrow cells permanently. White cells and platelets are often raised too. PV is diagnosed in roughly 1 to 3 people per 100,000 each year, most often in their sixties, though a meaningful minority are diagnosed in their thirties and forties.

Essential thrombocythemia is defined by too many platelets, the cell fragments that start a clot. About half of people with ET carry the JAK2 mutation; most of the rest carry a mutation in a gene called CALR, and a small number carry one in MPL. ET skews younger and more female than PV, and it is frequently found by accident on a routine blood count in someone who feels perfectly well.

The symptoms that bring people to a doctor, or that they live with for years without a name, are worth knowing because some overlap with cosmetic complaints:

  • A ruddy, flushed face, sometimes with a reddish-purple tinge to the lips, ears, and palms, caused by the sheer volume of red cells in the skin's small vessels.
  • Itching after a warm bath or shower (aquagenic pruritus), reported by a large share of people with PV, often before diagnosis.
  • Erythromelalgia, episodes of burning pain, redness, and warmth in the hands or feet, which classically responds to aspirin.
  • Headaches, dizziness, visual disturbances, and ringing in the ears, related to thick blood flowing through small vessels.
  • An enlarged spleen, sometimes felt as fullness or discomfort under the left ribs, or early fullness after small meals.
  • Unexplained blood clots, including clots in unusual places such as the veins of the liver and intestines (Budd-Chiari syndrome and portal vein thrombosis); MPNs are one of the leading causes of these clots, and in some patients a clot is the first sign of the disease.

The surgical relevance follows directly. The ordinary risk factors for clots after cosmetic surgery, described in our piece on blood clots after plastic surgery, are long operations, immobility, abdominal tightening, hormones, and obesity. An uncontrolled MPN adds a blood that is primed to clot in the first place. Older studies of people with uncontrolled polycythemia who underwent surgery reported complication rates that would be unacceptable for any elective procedure, with clots and bleeding both common, and far lower rates in those whose counts had been brought under control first. More recent data are more reassuring but not trivial: a widely cited Italian study published in the journal Blood followed more than 300 operations in patients with PV and ET and found that, despite preventive measures, roughly 8 percent were followed by a clot and about 7 percent by major bleeding within three months.

None of this means cosmetic surgery is off the table. It means that, for a person with an MPN, elective surgery is a hematology question first and a cosmetic question second.

Before booking: controlled counts, a hematologist in the loop, and the questions on the intake form

The short answer: before elective surgery, a person with PV or ET should have blood counts that have been stably controlled for a period their hematologist is comfortable with, a hematocrit below 45 percent in PV, a platelet count in a range their hematologist accepts, a check for acquired von Willebrand syndrome if platelets have been very high, and a written plan agreed between hematologist, surgeon, and anesthesiologist.

The hematocrit. In PV, the single most important number is the hematocrit, the percentage of the blood made up of red cells. A landmark Italian trial published in the New England Journal of Medicine in 2013, known as CYTO-PV, randomized people with PV to a hematocrit target below 45 percent or a looser target of 45 to 50 percent. The tighter group had substantially fewer deaths from cardiovascular causes and major clots, roughly a fourfold difference. Below 45 percent has since become the standard target in international guidance, including from the European LeukemiaNet. For elective surgery, it is not enough to have hit that number once. Most hematologists want it held there consistently for some time before an operation, because a hematocrit that bounces between 43 and 52 between blood draws is a hematocrit that will be wherever it happens to be on the day of surgery.

The platelet count. In ET, and in PV with high platelets, the platelet count matters, but in a more complicated way than "lower is safer." Very high platelet counts, typically above 1,000,000 per microliter (often written as 1,000 x 10^9/L) and sometimes lower, can cause acquired von Willebrand syndrome: the excess platelets soak up and break down von Willebrand factor, a protein the blood needs to form a clot at the site of an injury. The result is a person with a clotting disease who bleeds easily. A test of von Willebrand factor activity is a sensible part of preoperative work-up in anyone whose platelets have been markedly elevated, and it changes the aspirin decision discussed below. The mechanism and the tests are covered in our piece on bleeding disorders and cosmetic surgery.

Your clot history. Hematologists sort people with MPNs into risk groups, and the two features that matter most are age over 60 and a past clot. Someone who has had a deep vein thrombosis, a pulmonary embolism, a stroke, a heart attack, or a clot in the abdominal veins is at high risk of another, and may already be on a blood thinner. If you are on warfarin, apixaban, rivaroxaban, or another anticoagulant, the planning in our piece on blood thinners before cosmetic surgery applies, along with the MPN-specific issues here, and the conversation about whether a purely cosmetic operation is worth interrupting that anticoagulation is a serious one.

The spleen and the liver. An enlarged spleen sits in the upper left abdomen, beneath the ribs, and in some patients it extends well below them. That matters for anyone considering liposuction of the upper abdomen or flanks or a tummy tuck, and the most recent ultrasound or CT report should be in the surgeon's hands. People with a history of abdominal vein clots may also have changes in the liver and in the veins of the abdominal wall that matter for any operation that lifts abdominal skin.

The intake form. Back to the principal's dilemma. The honest answer to "bleeding or clotting disorder" is to write out the diagnosis in words, list the medications, and attach the last two or three blood counts. A tick box does not convey "PV, JAK2 positive, hematocrit 44 on hydroxyurea, aspirin daily, no clots." The risk scoring tools many plastic surgeons use to plan clot prevention, such as the Caprini score, are checklists, and an MPN does not always map neatly onto one of the boxes; the surgeon needs to hear it explicitly. The point of preoperative testing in this setting is not only a fresh blood count, but a conversation about what the numbers mean.

Secondary erythrocytosis is not the same thing. One clarification belongs in any article on this topic, because it applies to many more cosmetic patients than PV does. A high hematocrit is often caused by something other than a marrow disease: testosterone therapy, smoking, untreated sleep apnea, living at altitude, and, more recently recognized, SGLT2 inhibitor diabetes drugs. Testosterone in particular is common among men seeking body contouring, and it reliably raises hematocrit; endocrine guidelines advise holding or reducing it when the hematocrit climbs above roughly 54 percent. These secondary causes are not cancers and are managed differently, but a high hematocrit is still a high hematocrit on the day of surgery, and a surgeon who sees one should ask why. The links to smoking and sleep apnea are covered in our pieces on smoking cessation timelines and sleep apnea before cosmetic surgery. If a JAK2 test has never been done on an unexplained high count, a planned operation is a reasonable prompt to ask for one.

Medications: aspirin, hydroxyurea, interferon, ruxolitinib, anagrelide, and why iron is the wrong supplement

The short answer: nearly every drug used to control PV and ET has a surgical consequence, and two pieces of standard cosmetic surgery advice, stopping aspirin for ten days and taking iron to build up blood before surgery, can be exactly the wrong thing for a person with an MPN unless their hematologist says otherwise.

Aspirin. Low-dose aspirin is a cornerstone of PV treatment and of most ET treatment, because it reduces clots and relieves erythromelalgia and some headaches. Cosmetic surgeons routinely ask patients to stop aspirin a week or more before surgery to reduce bleeding, as described in our supplements and medications stop list. For a person with an MPN, that instruction should not be followed automatically. Stopping aspirin removes a protection that exists for a reason, during the very weeks when clot risk peaks. Whether to continue it, stop it briefly, or stop it longer depends on the operation (a facelift, where a small bleed under the skin becomes a hematoma, is a different calculation from a small liposuction), on the person's clot history, and on whether acquired von Willebrand syndrome is present, in which case aspirin can worsen bleeding considerably. The decision belongs to the hematologist and surgeon together, in writing.

Phlebotomy and iron. Regular blood removal, or therapeutic phlebotomy, is how most people with PV keep their hematocrit below 45 percent. It works partly by making the body iron deficient, which limits how fast the marrow can make red cells. That iron deficiency is intentional. Meanwhile, a common piece of preoperative advice, particularly before large body contouring operations, is to take iron to build up blood stores, an approach described in our piece on anemia and blood loss before cosmetic surgery. In PV, iron supplements can drive the hematocrit up quickly and undo months of careful control. Do not take iron, including the iron hidden in many multivitamins and "energy" supplements, without the hematologist's agreement. The timing of the last phlebotomy before surgery is a planning question in its own right, because surgery itself involves blood loss and fluid shifts, and the goal is a hematocrit safely below target on the day without leaving someone anemic and dizzy.

Hydroxyurea. The most widely used drug to lower blood counts in PV and ET, hydroxyurea is a daily capsule that suppresses marrow production. It is usually continued through surgery, though the hematologist decides. It has several effects on the skin that matter to plastic surgeons. Long-term use is associated with painful leg ulcers, typically around the ankles, which heal slowly; with thinning and dryness of the skin; with darkened nails; and with an increased risk of skin cancers, particularly squamous cell carcinoma on sun-exposed skin. Anyone on hydroxyurea who is planning a thigh lift, leg liposuction, or any operation near the lower legs should mention a history of ulcers, and anyone on it should have regular skin checks, because the facial lesion a patient brings to a cosmetic consultation may need a biopsy before it needs a laser. Our piece on Mohs reconstruction for facial skin cancer covers what happens when it does.

Interferon. Ropeginterferon alfa-2b, sold as Besremi and approved by the FDA for PV in 2021, and older forms of pegylated interferon are increasingly used, particularly in younger patients, because they can lower the burden of the JAK2 mutation itself. Interferon can cause fatigue, flu-like symptoms, depression, and thyroid problems. Mood and thyroid function are worth checking before an elective operation, and the drug's timing around surgery is a question for the prescriber.

Ruxolitinib. Sold as Jakafi, ruxolitinib blocks the JAK signaling pathway and is approved for PV in people who cannot tolerate hydroxyurea or do not respond to it. Two surgical points matter. First, it should not be stopped abruptly: a discontinuation syndrome, with a rapid return of symptoms and spleen enlargement, has been described, so any pause must be planned by the hematologist. Second, it suppresses parts of the immune system, raising the risk of infections, including shingles, and it is associated with an increased risk of non-melanoma skin cancers. The infection risk is relevant to wound healing and to the antibiotic plan, discussed in our piece on antibiotics after cosmetic surgery.

Anagrelide. Used in ET to lower platelets specifically, anagrelide can cause palpitations, fluid retention, and headaches, and it has effects on platelet function and on the heart. An electrocardiogram and attention to heart rhythm belong in the preoperative plan for anyone taking it.

Hormones and testosterone. Estrogen-containing birth control and hormone therapy raise clot risk in anyone, and in a person with an MPN most hematologists advise avoiding estrogen altogether. The general cosmetic surgery logic is covered in our piece on birth control before cosmetic surgery. Testosterone, discussed above, raises hematocrit and is a particularly poor partner for PV.

Tranexamic acid. Many surgeons now use tranexamic acid to reduce bleeding and bruising during facelifts, breast reductions, and body contouring, as explained in our piece on tranexamic acid in cosmetic surgery. The large trials that established its safety generally did not focus on people with active blood cancers or a history of clots, and a person with PV or ET who has had a clot should not receive it without a deliberate decision by the surgeon and hematologist. It is not automatically forbidden, but it should never be given on autopilot.

"For most surgical patients, stopping aspirin and taking iron before surgery are sensible precautions. For a person with polycythemia vera, both can quietly undo the very things that keep their blood from clotting."

Procedure by procedure: liposuction, tummy tuck, BBL, breast surgery, facelift, and lasers for facial redness

The short answer: the larger, longer, and more fluid-intensive the operation, the more an MPN matters; body contouring needs the most careful planning, breast surgery and facelifts change mainly through bleeding and clot management, and the facial redness of PV is not a cosmetic problem a laser can fix.

Liposuction. Liposuction removes fat and fluid together, and large-volume liposuction causes substantial shifts of fluid between the blood and the tissues over the following day. As fluid leaves the bloodstream, the blood concentrates, and the hematocrit rises. In someone whose hematocrit starts at 44 percent, that rise can carry it above the target precisely when clot risk is highest. The answer is not to avoid liposuction entirely but to limit the volume, stage larger treatments into separate sessions, keep the operation shorter, and plan fluids and blood counts deliberately. The limits on the local anesthetic in the injected fluid, described in our piece on lidocaine toxicity in tumescent liposuction, apply as they do for everyone. For a person with an enlarged spleen, liposuction of the left upper abdomen and left flank should only be done with up-to-date imaging showing exactly where the spleen sits, because a cannula that enters an enlarged spleen can cause catastrophic bleeding.

Tummy tuck. An abdominoplasty is among the cosmetic operations with the highest rates of blood clots, because it combines a long operation, tightening of the abdominal wall that slows blood return from the legs, and reduced mobility in the days after. Add an MPN, and most surgeons and hematologists will want blood thinner injections after surgery, often for longer than a standard course, alongside early walking and mechanical compression of the legs. Combined procedures, such as a tummy tuck with liposuction and a breast lift in a single mommy makeover, lengthen the operation and add up clot risk; for a person with PV or ET, staging procedures into separate, shorter operations is often the safer choice even if it means more recovery time overall. A mini tummy tuck, which treats only the lower abdomen and usually takes less time, may be worth discussing for those whose concern is limited. A history of abdominal vein clots or liver disease from Budd-Chiari syndrome changes the circulation of the abdominal wall, and the planning resembles that described in our piece on fatty liver disease and cosmetic surgery, where liver function and abdominal vein pressure shape what is safe.

Brazilian butt lift. A BBL combines liposuction with fat injection into the buttocks, and its most feared complication, fat embolism, is unrelated to the MPN. But it typically includes extensive liposuction and requires patients to avoid sitting and lying on their backs, which tends to reduce how much they move in the first days. For someone with an MPN, those factors add up, and the safety principles in our piece on BBL safety protocols should be applied with even less tolerance for long, high-volume operations.

Breast surgery. Breast augmentation, lift, and reduction are shorter and generally lower in clot risk than abdominal surgery, but bleeding matters more: a hematoma in a breast pocket usually means a return to the operating room. A person with ET and very high platelets, or with acquired von Willebrand syndrome, or who has continued aspirin, faces a higher risk of postoperative bleeding, and the surgeon's technique, drain use, and blood pressure control matter accordingly. For breast reduction, which is longer and removes more tissue, the planning moves closer to that for body contouring. Men with PV who are considering gynecomastia surgery, especially those on testosterone, should have the hematocrit question settled first; the hormone links are discussed in our piece on gynecomastia surgery.

Facelift. Hematoma is the most common significant complication of a facelift, and its main drivers are blood pressure and anything that impairs clotting. Continued aspirin, acquired von Willebrand syndrome, and the blood pressure rises that some people with PV experience all push in the wrong direction. Facelifts are usually not long enough to raise clot risk dramatically on their own, but in someone with an MPN they still need a clot prevention plan. Many patients with PV and ET have facelifts without incident; the ones who do well are those whose aspirin plan and blood pressure were settled before the day.

Facial redness and lasers. This is the point most often missed at cosmetic consultations. The flushed, ruddy face of polycythemia vera, sometimes called plethora, can look like rosacea or broken capillaries, and patients sometimes book vascular laser or intense pulsed light treatments to fix it. Those treatments target visible vessels, as described in our piece on facial redness and vascular lasers, and they can help with genuine broken capillaries, but they cannot reduce the overall redness caused by too many red cells in the blood. The color usually improves when the hematocrit is controlled. A practitioner who sees a deeply flushed face, especially with reddish palms and a history of itching after showers, and suggests a blood test before a laser package, is doing their job. The same caution applies to nose redness that looks like rhinophyma but comes with none of its thickening.

Itching that predates surgery. The aquagenic itch of PV can flare after surgery, particularly after the first showers, and is easily confused with the healing itch described in our piece on itching after plastic surgery. It is worth mentioning before surgery so that no one mistakes a familiar PV symptom for an allergic reaction to a dressing or an antibiotic.

The operating day and recovery: clot prevention, hydration, blood counts, and warning signs

The short answer: recovery with an MPN centers on preventing clots (blood thinner injections when the hematologist agrees, early walking, leg compression), staying well hydrated so the blood does not concentrate, rechecking blood counts, and treating any swollen leg, chest pain, shortness of breath, or severe abdominal pain as urgent.

Where to have surgery. For anything beyond a small procedure, a person with PV or ET is better served by a hospital or accredited surgical facility with ready access to blood tests, imaging, and a hematologist, than by a small office suite. Our piece on outpatient facility accreditation covers what to check. A longer, combined operation that might be acceptable for a healthy 40-year-old in an office setting deserves more caution in someone with an MPN.

Clot prevention. The usual layers of clot prevention after cosmetic surgery, which include compression devices on the calves during the operation, early walking, and in higher-risk patients injections of a low molecular weight heparin such as enoxaparin for a period afterward, are not optional extras for a person with PV or ET. The length of the injection course is a judgment call, and hematologists sometimes recommend continuing longer than surgeons are used to for a cosmetic operation, particularly after abdominal surgery. That has to be balanced against bleeding risk, which is why the plan should be agreed in advance rather than improvised on the day. Compression garments, discussed in our piece on compression garment evidence, support the contour result but are not a substitute for the measures that actually prevent clots.

Hydration. Dehydration concentrates the blood and pushes the hematocrit up. Fasting before anesthesia, nausea, blood loss, fluid shifts after liposuction, and pain that makes people reluctant to get up and drink all work against a person with PV in the first two days. The recovery plan should include a clear daily fluid target and a rule about when to call if urine becomes dark or scant.

Blood counts. A blood count the day after a larger operation and again during the first week or two helps catch a hematocrit that has drifted up, a platelet count that has spiked (platelets often rise after surgery as part of the normal healing response, and in ET that rise starts from an already high baseline), or unexpected blood loss. The hematologist may adjust hydroxyurea, schedule a phlebotomy, or change the clot prevention plan based on those numbers.

Travel. People with MPNs who travel for surgery face the additional clot risk of long flights shortly after an operation. Our piece on flying after cosmetic surgery covers the timing; for a person with PV or ET, it is a strong argument for having surgery close to home, where the hematologist can see you and the surgeon can see you again.

Warning signs. Some symptoms after surgery need a call the same day, and a few need emergency services:

  • A swollen, painful, or warm calf or thigh, especially on one side, which may signal a deep vein thrombosis.
  • Sudden shortness of breath, chest pain, a racing heart, or coughing blood, which may signal a pulmonary embolism and warrant emergency care.
  • Severe abdominal pain, sudden abdominal swelling, or pain under the left ribs, which in someone with an MPN may signal a clot in the abdominal veins or a problem with the spleen, not simply surgical discomfort.
  • A sudden, expanding swelling under the skin of the face, breast, or abdomen, which may signal a hematoma.
  • Sudden weakness, numbness, slurred speech, or loss of vision, which may signal a stroke and warrant emergency care.

Healing. Wounds in people with MPNs generally heal normally, but those on hydroxyurea or ruxolitinib may heal more slowly, and a slow-healing area on the lower leg in someone on hydroxyurea deserves early attention rather than watchful waiting. Infections should be treated promptly in anyone on ruxolitinib.

The longer view. An MPN is a lifelong condition, and the cosmetic decision sits inside a longer medical story. Counts change over years, medications change, and some people's disease slowly progresses. That is not a reason to forgo cosmetic surgery, but it is a reason to choose a time when the disease is stable, to prefer shorter and staged operations over long combined ones, and to keep the hematologist involved at every step. A surgeon who suggests waiting a few more months until your counts have been steady is not being obstructive. They are reducing the chance that an elective operation becomes the event that defines the next decade.

The honest summary

Polycythemia vera and essential thrombocythemia do not rule out cosmetic surgery, but they change it more than most chronic conditions. Both raise the risk of blood clots after surgery, and very high platelet counts can paradoxically cause bleeding through acquired von Willebrand syndrome. The standard cosmetic surgery advice to stop aspirin for a week and take iron to build up blood can be harmful in PV, and several of the drugs used to control MPNs, including hydroxyurea and ruxolitinib, carry skin, healing, or infection effects that matter to a plastic surgeon.

The practical rules are straightforward. Make sure your counts have been stably controlled, with a hematocrit below 45 percent in PV, for a period your hematologist accepts before booking anything elective. Write out your diagnosis, your medications, and your recent blood counts on the intake form rather than ticking a box. Get a written plan, agreed between your hematologist and surgeon, for aspirin, hydroxyurea, ruxolitinib, phlebotomy, and clot prevention injections. Do not take iron or stop aspirin on general advice. Ask for a check of von Willebrand factor if your platelets have been very high. Choose a facility with ready access to blood tests and a hematologist, prefer shorter and staged operations, stay well hydrated, and treat a swollen leg, sudden breathlessness, or severe abdominal pain as an emergency.

Then be realistic about what each operation can do. Liposuction in smaller sessions, a tummy tuck done as a standalone procedure rather than part of a long combined operation, and a facial redness plan that starts with your hematocrit rather than a laser may be less efficient, but they are safer. If a surgeon hears "polycythemia vera" and does not ask for your blood counts, your hematologist's name, or your aspirin plan, it is worth getting a second consultation.